September 07, 2017
A Swiss pharmaceuticals company is asking a Virginia federal court not only to confirm a $2.7 million arbitral award against a Japanese company following a dispute over a cystic fibrosis drug but also to find that the company fraudulently transferred certain patents in an attempt to avoid paying up.